The Future of Orthopaedic Surgery: Ten Developments That Will Shape the Next Decade

Predicting the future of any rapidly evolving field is an exercise in informed extrapolation rather than certainty — and I hold these projections with the intellectual humility that the pace of change in medicine demands. What I can offer is a reading of the trajectories that are already clear, the technologies already in clinical use whose adoption will accelerate, and the structural changes already underway whose implications will become fully visible over the next decade.

1. AI-integrated clinical pathways will become standard

The question of whether AI will be integrated into orthopaedic clinical pathways is already answered. The question is how comprehensively, how safely, and with what governance. Within ten years, AI-assisted fracture detection, PROM analysis, risk stratification, and outcome prediction will be components of most major orthopaedic pathways in well-resourced health systems — not because they are novel, but because the evidence for their clinical value will have accumulated to the point where their absence becomes indefensible.

2. Biological augmentation will extend what surgery can offer

The biology of tendon, cartilage, and bone repair is being understood at a cellular and molecular level that is generating therapeutic targets with real clinical potential. Scaffold-enhanced tendon repair, growth factor delivery systems for fracture healing augmentation, and cell-based cartilage repair strategies will move progressively from clinical trial to mainstream practice as the evidence base matures and the cost of biological product manufacturing reduces.

3. Personalised implants will become the standard for complex reconstruction

Patient-specific implants — designed from the individual patient's imaging data and manufactured with additive techniques that produce both anatomical accuracy and biological integration properties — will progressively replace standard implant systems for revision surgery, complex reconstruction, and tumour management. The cost barrier, which currently limits patient-specific implants to complex cases, will reduce as manufacturing processes mature.

4. Global collaborative evidence will replace single-centre research

The federated research architecture being built through networks like OrthoGlobe will, within ten years, enable the routine conduct of multinational studies with the statistical power, demographic diversity, and real-world representativeness that single-centre research cannot approach. The evidence base that guides orthopaedic practice will be genuinely global — and genuinely equitable — in ways that it is not today.

5–10: The remaining transformations

Preventive musculoskeletal medicine — systematic screening and early intervention for conditions before they become surgical — will grow as health systems recognise the cost and quality advantages of prevention over treatment. Outcome-based reimbursement, where payment is linked to patient-reported outcomes rather than procedure volume, will reshape the incentives of orthopaedic practice in profound ways. Digital rehabilitation, delivered at scale through technology rather than constrained by physiotherapy capacity, will extend access to evidence-based recovery support. Surgical robotics will achieve the evidence base that justifies mainstream adoption in knee, hip, and shoulder arthroplasty. And the surgeon-scientist who moves fluidly between clinical practice, research, and innovation will become not the exception but the model for what excellent orthopaedic practice looks like.